GlassScriptPhysician profile
Shan C Lin
NPI 1730131236
$374,003.30
in general payments reported to CMS, 2019-2025
22 companies · $13K in 2025
The $13K reported for 2025 was more than what 96% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $106K · 2020: $57K · 2021: $50K · 2022: $89K · 2023: $26K · 2024: $33K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $38K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $24K · Food and Beverage: $4,779 · Honoraria: $2,600 · Travel and Lodging: $1,863 · Long Term Medical Supply Or Device Loan: $501.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $38,300.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $23,737.50 |
| Food and Beverage | $4,778.70 |
| Honoraria | $2,600.00 |
| Travel and Lodging | $1,863.21 |
| Long Term Medical Supply Or Device Loan | $501.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iridex Corporation | $149,524.79 | 2019-2024 | |
| Aerie Pharmaceuticals, INC. | $129,278.45 | 2019-2021 | |
| Alcon Vision LLC | $38,271.62 | 2021-2025 | Hydrus Microstent, Rocklatan |
| Bausch & Lomb Americas INC. | $28,187.10 | 2022-2025 | Vyzulta, Miebo, Xiidra |
| Allergan, INC. | $13,322.45 | 2019-2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $10,102.22 | 2019-2021 | |
| Dompe US, INC. | $2,379.49 | 2023-2024 | Oxervate |
| New World Medical,INC. | $865.08 | 2021-2025 | Clearpath, Kahook Dual Blade, Ahmed Glaucoma Valve |
| Carl Zeiss Meditec USA, INC. | $526.06 | 2023 | Lumera, Lumera 700 |
| Sight Sciences, INC. | $461.41 | 2019-2024 | Omni Surgical System, Sion Surgical Instrument |
| Thea Pharma INC. | $235.43 | 2023-2025 | Iyuzeh |
| Beaver-Visitec International, INC. | $223.61 | 2023-2025 | |
| Abbvie INC. | $162.14 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $109.17 | 2019 | |
| Oyster Point Pharma, INC. | $97.50 | 2025 | Tyrvaya, Ryzumvi |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $71.05 | 2023 | |
| Sun Pharmaceutical Industries INC. | $48.66 | 2019-2022 | |
| Ivantis, INC | $41.19 | 2020-2021 | |
| Rayner Intraocular Lenses Limited | $34.21 | 2023 | Omidria, Rayone Aspheric, Rayone Emv |
| Amgen INC. | $28.92 | 2024 | Tepezza |
| Johnson & Johnson Surgical Vision, INC. | $18.30 | 2025 | Veritas Vision System |
| Astellas Pharma US INC | $14.45 | 2024 | Izervay |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shan Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.